Scienture Holdings, Inc. (Nasdaq: SCNX) has entered into a securities purchase agreement for a registered direct offering.
The offering includes 3,225,000 shares of common stock at an offering price of $1.20 per share, with gross proceeds around $3.9 million.
Maxim Group LLC is the sole placement agent for the offering, expected to close on August 15, 2025.
Offering Details
3,225,000 shares of common stock at $1.20 per share, expected proceeds of $3.9 million.
Placement Agent
Maxim Group LLC is the sole placement agent for the offering.
Closing Date
The offering is set to close on August 15, 2025, subject to customary conditions.
- The offering provides Scienture Holdings with additional funding for its pharmaceutical operations.
- Maxim Group LLC's involvement enhances the credibility of the offering.
The registered direct offering signifies a strategic move by Scienture Holdings to strengthen its position in the pharmaceutical market.